1. Home
  2. OBDC vs KRYS Comparison

OBDC vs KRYS Comparison

Compare OBDC & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Owl Capital Corporation

OBDC

Blue Owl Capital Corporation

HOLD

Current Price

$11.51

Market Cap

5.6B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$265.29

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBDC
KRYS
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
7.8B
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
OBDC
KRYS
Price
$11.51
$265.29
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$14.28
$297.60
AVG Volume (30 Days)
7.3M
267.5K
Earning Date
04-27-2026
01-01-0001
Dividend Yield
13.13%
N/A
EPS Growth
N/A
128.00
EPS
1.24
6.84
Revenue
N/A
$389,130,000.00
Revenue This Year
N/A
$44.50
Revenue Next Year
N/A
$34.79
P/E Ratio
$9.32
$38.70
Revenue Growth
N/A
33.94
52 Week Low
$10.70
$123.03
52 Week High
$15.36
$298.30

Technical Indicators

Market Signals
Indicator
OBDC
KRYS
Relative Strength Index (RSI) 45.12 47.61
Support Level $11.15 $255.65
Resistance Level $14.67 $293.60
Average True Range (ATR) 0.44 12.28
MACD 0.03 -1.64
Stochastic Oscillator 46.88 29.10

Price Performance

Historical Comparison
OBDC
KRYS

About OBDC Blue Owl Capital Corporation

Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: